Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-21

FDA Approved: REVATIO — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for REVATIO (sildenafil citrate) filed by Viatris Specialty LLC. The action typically updates or expands the product’s l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REVATIO (SILDENAFIL CITRATE)

Snippet

SUPPL AP for REVATIO (SILDENAFIL CITRATE)